Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

People with multiple sclerosis (MS) often stop taking disease-modifying therapy as they transition from relapsing-remitting MS to secondary progressive MS. This study shows that people who stop stop ...

In this latest episode of Tuning In to the C-Suite podcast, Briana Contreras, an editor with MHE had the pleasure of meeting ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, ...

Aucatzyl is a CAR T-cell therapy that targets CD19 and has been designed to minimize excessive activation of the programmed T ...

The panelist discusses how intrauterine insemination is typically considered for patients with unexplained infertility, mild ...

Laila Gharzai, M.D., LLM, from the Department of Radiation Oncology at Northwestern University explains the concept of financial toxicity and how it affects breast cancer treatment outcomes. The idea ...

Kenan R. Omurtag, M.D., discusses how assisted reproductive technology encompasses various medical procedures like in vitro fertilization, intracytoplasmic sperm injection and gamete donation to help ...

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

Member experience, outcomes and medication adherence are the key areas of performance that Medicare Advantage plans should ...

Medicare Part D to Cover Wegovy for Obese Patients at-risk for Heart Disease ...

CT scans of the lungs can pick up early-stage lung cancers, but across the nation, less then 20% of those who are eligible ...